Stay updated with breaking news from Robertb Ford. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abbott Nutrition announced today that it will resume production at their formula plant in Sturgis after entering into a consent decree with the U.S. Food and Drug Administration.
The relaunch notice comes a week after the DOJ confirmed a tentative agreement with Abbott to resolve safety issues at the U.S.' largest plant for infant formula.
Abbott (NYSE: ABT) today announced that the U.S. District Court for the Western District of Michigan has amended the recent consent decree allowing Abbott to release limited quantities of its EleCare® specialty amino acid-based formulas that were previously on hold following the Feb. 17 recall of some powder infant ...
/PRNewswire/ -- Abbott (NYSE: ABT) today announced that the U.S. District Court for the Western District of Michigan has amended the recent consent decree...
/PRNewswire/ -- Abbott (NYSE: ABT) today announced that the U.S. District Court for the Western District of Michigan has amended the recent consent decree...